Venture Capital Funding Issue Splits House, Senate On SBIR Reauthorization
This article was originally published in The Gray Sheet
Executive Summary
While Small Business Innovation Research reauthorization bills are making headway through the House and Senate, the two bodies differ on how much SBIR funding can go to start-up firms that are majority-owned by venture capitalists and other private investors.
You may also be interested in...
Updated SBIR Grants May Already Need A Fix To Keep Up With The Times
Just as the Small Business Innovation Research program achieved a congressional fix for the knotty problem of letting companies with VC support apply for the “valley of death” grants, it may have fallen behind again with its de facto exclusion of virtual start-ups. Companies have until July 16 to comment on the program’s updated implementing regulation.
Reform Of Federal Small Business Research Funding Program Delayed Again
Congress has again put off longer term reauthorization and reform of the Small Business Innovation Research Program, as the House and Senate remain at odds over the appropriateness of funding majority venture-capital-backed companies
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add a new product – Tibsovo, Servier’s treatment for IDH1-mutated acute myeloid leukemia and IDH1-mutated cholangiocarcinoma.